{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:41:13Z","timestamp":1783464073442,"version":"3.55.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Stomach adenocarcinoma (STAD) is one of the primary contributors to deaths that are due to cancer globally. At the moment, STAD does not have any universally acknowledged biological markers, and its predictive, preventive, and personalized medicine (PPPM) remains sufficient. Oxidative stress can promote cancer by increasing mutagenicity, genomic instability, cell survival, proliferation, and stress resistance pathways. As a direct and indirect result of oncogenic mutations, cancer depends on cellular metabolic reprogramming. However, their roles in STAD remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>743 STAD samples from GEO and TCGA platforms were selected. Oxidative stress and metabolism-related genes (OMRGs) were acquired from the GeneCard Database. A pan-cancer analysis of 22 OMRGs was first performed. We categorized STAD samples by OMRG mRNA levels. Additionally, we explored the link between oxidative metabolism scores and prognosis, immune checkpoints, immune cell infiltration, and sensitivity to targeted drugs. A series of bioinformatics technologies were employed to further construct the OMRG-based prognostic model and clinical-associated nomogram.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 22 OMRGs that could evaluate the prognoses of patients with STAD. Pan-cancer analysis concluded and highlighted the crucial part of OMRGs in the appearance and development of STAD. Subsequently, 743 STAD samples were categorized into three clusters with the enrichment scores being C2 (upregulated) &amp;gt; C3 (normal) &amp;gt; C1 (downregulated). Patients in C2 had the lowest OS rate, while C1 had the opposite. Oxidative metabolic score significantly correlates with immune cells and immune checkpoints. Drug sensitivity results reveal that a more tailored treatment can be designed based on OMRG. The OMRG-based molecular signature and clinical nomogram have good accuracy for predicting the adverse events of patients with STAD. Both transcriptional and translational levels of ANXA5, APOD, and SLC25A15 exhibited significantly higher in STAD samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The OMRG clusters and risk model accurately predicted prognosis and personalized medicine. Based on this model, high-risk patients might be identified in the early stage so that they can receive specialized care and preventative measures, and choose targeted drug beneficiaries to deliver individualized medical services. Our results showed oxidative metabolism in STAD and led to a new route for improving PPPM for STAD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1090906","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T04:49:31Z","timestamp":1676263771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Identification and characterization of a novel molecular classification incorporating oxidative stress and metabolism-related genes for stomach adenocarcinoma in the framework of predictive, preventive, and personalized medicine"],"prefix":"10.3389","volume":"14","author":[{"given":"Ying","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongkuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3946","article-title":"Influence of antidepressants on the convulsive action of corazole and strychnine","volume":"39","author":"Chugunov","year":"1976","journal-title":"Farmakol Toksikol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4111\/icu.2018.59.5.285","article-title":"Immune checkpoint inhibitors for urothelial carcinoma","volume":"59","author":"Kim","year":"2018","journal-title":"Investig Clin Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30481-9","article-title":"Pertuzumab plus trastuzumab and chemotherapy for Her2-positive metastatic gastric or gastro-oesophageal junction cancer (Jacob): Final analysis of a double-blind, randomised, placebo-controlled phase 3 study","volume":"19","author":"Tabernero","year":"2018","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29724","article-title":"Mirnas, oxidative stress, and cancer: A comprehensive and updated review","volume":"235","author":"Ebrahimi","year":"2020","journal-title":"J Cell Physiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00041","article-title":"Mitochondrial and oxidative stress-mediated activation of protein kinase D1 and its importance in pancreatic cancer","volume":"7","author":"Doppler","year":"2017","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2016.12.011","article-title":"Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles","volume":"11","author":"Morry","year":"2017","journal-title":"Redox Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/cdd.2014.16","article-title":"Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation","volume":"21","author":"Ogrunc","year":"2014","journal-title":"Cell Death Differ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature11066","article-title":"Ampk regulates nadph homeostasis to promote tumour cell survival during energy stress","volume":"485","author":"Jeon","year":"2012","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and nf-kappab signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-14-0250","article-title":"Serine catabolism regulates mitochondrial redox control during hypoxia","volume":"4","author":"Ye","year":"2014","journal-title":"Cancer Discovery"},{"key":"B13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbcan.2018.06.005","article-title":"Metabolic reprogramming for cancer cells and their microenvironment: Beyond the warburg effect","volume":"1870","author":"Sun","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discovery"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: The emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.171","article-title":"From tumour heterogeneity to advances in precision treatment of colorectal cancer","volume":"14","author":"Punt","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01065-5","article-title":"Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence","volume":"23","author":"Kaji","year":"2020","journal-title":"Gastric Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636917","article-title":"Serum metabolic profiling analysis of chronic gastritis and gastric cancer by untargeted metabolomics","volume":"11","author":"Yu","year":"2021","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: Immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12885-020-06814-4","article-title":"Deconvolution of diffuse gastric cancer and the suppression of Cd34 on the Balb\/C nude mice model","volume":"20","author":"Yoon","year":"2020","journal-title":"BMC Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12920-022-01312-x","article-title":"Identifying the role of transient receptor potential channels (Trps) in kidney renal clear cell carcinoma and their potential therapeutic significances using genomic and transcriptome analyses","volume":"15","author":"Ren","year":"2022","journal-title":"BMC Med Genomics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.985911","article-title":"Comprehensive characterization of extracellular matrix-related genes in paad identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with in vivo and vitro validation","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2021.6888","article-title":"Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma","volume":"22","author":"Wang","year":"2022","journal-title":"Bosn J Basic Med Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.951137","article-title":"Integration of transcriptomics, proteomics, and metabolomics data to reveal Her2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1018685","article-title":"Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of hnscc","volume":"13","author":"Chi","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02689-y","article-title":"Three Hematologic\/Immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis","volume":"19","author":"Cheng","year":"2021","journal-title":"J Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (Msigdb) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10414","article-title":"Classification of ovarian cancer associated with Brca1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling","volume":"8","author":"Wei","year":"2020","journal-title":"PeerJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8128","article-title":"Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma","volume":"7","author":"Yue","year":"2019","journal-title":"PeerJ"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","article-title":"Prrophetic: An r package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.984273","article-title":"A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration","volume":"13","author":"Chi","year":"2022","journal-title":"Front Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.983672","article-title":"The prognostic value of micrornas associated with fatty acid metabolism in head and neck squamous cell carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"Gepia: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","article-title":"Proteomics. tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cell.2013.03.008","article-title":"Interplay between the cancer genome and epigenome","volume":"153","author":"Shen","year":"2013","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (Time) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6635526","article-title":"Construction and validation of a ferroptosis-related prognostic model for gastric cancer","volume":"2021","author":"Jiang","year":"2021","journal-title":"J Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.676485","article-title":"The pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer","volume":"9","author":"Shao","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12967-020-02366-0","article-title":"Development and validation of a hypoxia-Immune-Based microenvironment gene signature for risk stratification in gastric cancer","volume":"18","author":"Liu","year":"2020","journal-title":"J Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7150\/jca.40866","article-title":"Expression status and prognostic value of M6a-associated genes in gastric cancer","volume":"11","author":"Guan","year":"2020","journal-title":"J Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.744677","article-title":"Weighted gene Co-expression network analysis identifies a cancer-associated fibroblast signature for predicting prognosis and therapeutic responses in gastric cancer","volume":"8","author":"Zheng","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41598-021-82976-w","article-title":"Integrated analysis identifies oxidative stress genes associated with progression and prognosis in gastric cancer","volume":"11","author":"Wu","year":"2021","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683582","article-title":"Novel prognostic biomarkers in gastric cancer: Cgb5, Mknk2, and Pappa2","volume":"11","author":"Qin","year":"2021","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i6.2046","article-title":"Glucose metabolism in gastric cancer: The cutting-edge","volume":"22","author":"Yuan","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.916661","article-title":"The role of lipid metabolism in gastric cancer","volume":"12","author":"Cui","year":"2022","journal-title":"Front Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.09.058","article-title":"Molecular pathways associated with oxidative stress in diabetes mellitus","volume":"108","author":"Ighodaro","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13167-015-0030-6","article-title":"Epma position paper in cancer: Current overview and future perspectives","volume":"6","author":"Grech","year":"2015","journal-title":"EPMA J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13167-016-0072-4","article-title":"Medicine in the early twenty-first century: Paradigm and anticipation - epma position paper 2016","volume":"7","author":"Golubnitschaja","year":"2016","journal-title":"EPMA J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21657","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.2847","article-title":"Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: Dose-finding study for the prospective multicenter, randomized, phase Ii\/Iii real-3 trial","volume":"28","author":"Okines","year":"2010","journal-title":"J Clin Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S1470-2045(14)70024-5","article-title":"Gefitinib for oesophageal cancer progressing after chemotherapy (Cog): A phase 3, multicentre, double-blind, placebo-controlled randomised trial","volume":"15","author":"Dutton","year":"2014","journal-title":"Lancet Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","article-title":"Targeting the microenvironment in solid tumors","volume":"65","author":"Belli","year":"2018","journal-title":"Cancer Treat Rev"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1090906\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T04:49:33Z","timestamp":1676263773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1090906\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":59,"alternative-id":["10.3389\/fendo.2023.1090906"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1090906","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"article-number":"1090906"}}